Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia
- PMID: 12925966
- DOI: 10.1002/ijc.11360
Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia
Abstract
We analyzed time trends in incidence of and mortality from malignant cutaneous melanoma in European populations since 1953. Data were extracted from the EUROCIM database of incidence data from 165 cancer registries. Mortality data were derived from the WHO database. During the 1990s, incidence rates were by far highest in northern and western Europe, whereas mortality was higher in males in eastern and southern Europe. Melanoma rates have been rising steadily, albeit with substantial geographic variation. In northern Europe, a deceleration in these trends occurred recently in persons aged under 70. Joinpoint analyses indicated that changes in these trends took place in the early 1980s. In western Europe, mortality rates have also recently leveled off [estimated annual percentage change (EAPC) from -13.6% (n.s.) to 3.3%], whereas in eastern and southern Europe both incidence and mortality rates are still increasing [incidence EAPCs 2.3-8.9%, mortality EAPCs -1.8% (n.s.) to 7.2%]. Models including the effects of age, period and birth cohort were required to adequately describe the rising incidence trends in most European populations, with a few exceptions. Time trends in mortality were adequately summarized on fitting either an age-cohort model (with the leveling off of rates starting in birth cohorts between 1930 and 1940) or an age-period-cohort model. The most plausible explanations for the deceleration or decline in the incidence and mortality trends in recent years in northern (and to a lesser extent western) Europe are earlier detection and more frequent excision of pigmented lesions and a growing public awareness of the dangers of excessive sunbathing.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.Eur J Cancer. 2004 May;40(7):1045-52. doi: 10.1016/j.ejca.2003.12.021. Eur J Cancer. 2004. PMID: 15093581
-
Cutaneous melanoma.Cancer Surv. 1994;19-20:219-40. Cancer Surv. 1994. PMID: 7534627 Review.
-
International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?Int J Cancer. 2013 Jan 15;132(2):385-400. doi: 10.1002/ijc.27616. Epub 2012 May 21. Int J Cancer. 2013. PMID: 22532371
-
Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.Acta Oncol. 2010 Jun;49(5):665-72. doi: 10.3109/02841861003702528. Acta Oncol. 2010. PMID: 20491525
-
Incidence, mortality and survival in cutaneous melanoma.J Plast Reconstr Aesthet Surg. 2007;60(1):32-40. doi: 10.1016/j.bjps.2006.05.008. Epub 2006 Jul 7. J Plast Reconstr Aesthet Surg. 2007. PMID: 17126264 Review.
Cited by
-
Delay in cutaneous melanoma diagnosis: Sequence analyses from suspicion to diagnosis in 211 patients.Medicine (Baltimore). 2016 Aug;95(31):e4396. doi: 10.1097/MD.0000000000004396. Medicine (Baltimore). 2016. PMID: 27495055 Free PMC article.
-
Improving outcomes in advanced malignant melanoma: update on systemic therapy.Drugs. 2005;65(6):733-43. doi: 10.2165/00003495-200565060-00002. Drugs. 2005. PMID: 15819587 Review.
-
Mechanical Intermittent Compression Affects the Progression Rate of Malignant Melanoma Cells in a Cycle Period-Dependent Manner.Diagnostics (Basel). 2021 Jun 18;11(6):1112. doi: 10.3390/diagnostics11061112. Diagnostics (Basel). 2021. PMID: 34207144 Free PMC article.
-
Diagnosing malignant melanoma in ambulatory care: a systematic review of clinical prediction rules.BMJ Open. 2017 Mar 6;7(3):e014096. doi: 10.1136/bmjopen-2016-014096. BMJ Open. 2017. PMID: 28264830 Free PMC article.
-
The cost of unresectable stage III or stage IV melanoma in Italy.J Exp Clin Cancer Res. 2012 Nov 1;31(1):91. doi: 10.1186/1756-9966-31-91. J Exp Clin Cancer Res. 2012. PMID: 23116062 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical